CLEC9A and cervical squamous cell carcinoma: Furthermore, we have constructed the first risk score model containing three NRmRNAs (CXCL8, CLEC9A and TAB2) in the TCGA cohort with independent prognostic ability in CESC patients, as well as validated the dataset established by random allocation.